Analgesics in Germany

Product Code EUR00647
Publication Date April 2011
Publisher Euromonitor
Product Type Report
Pages 32
ISBN Number not applicable
Change currency
PDF £600.00 €723 $949 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Analgesics in Germany

After the packaging size of paracetamol to be sold for self-medication was restricted to 10g per package in 2009, there have been further discussions to do the same for other analgesic products. Suggestions were made to restrict the OTC packaging size of aspirin to 10g per package, ibuprofen to 8g per package and diclofenac to 500mg per package. Packages with larger quantities would be classified as prescription medication.

Euromonitor International's Analgesics in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2006-2010, allowing you to identify the sectors driving growth. Forecasts to 2015 illustrate how the market is set to change.

Product coverage: Acne Treatments, Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Cough, Cold and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Diarrhoeal Remedies, First Aid Kits, Gauze, Tape and Other Wound Care, Haemorrhoid Treatments, Hair Loss Treatments, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Medicated Confectionery, Medicated Shampoos, Motion Sickness Remedies, Nappy (Diaper) Rash Treatments, NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical Allergy Remedies/Antihistamines, Topical Analgesics/Anaesthetic, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market's major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

  • Analgesics in Germany
  • Euromonitor International
  • April 2011
  • List of Contents and Headlines
    • Trends
    • Switches
    • Competitive Landscape
    • Prospects
    • Category Data
    • Bayer Vital GmbH in Consumer Health (germany)
    • Strategic Direction
    • Key Facts
  • Summary 1 Bayer Vital GmbH: Key Facts
  • Summary 2 Bayer Vital GmbH: Operational Indicators
    • Company Background
    • Production
  • Summary 3 Bayer Vital AG: Production Statistics 2010
    • Competitive Positioning
  • Summary 4 Bayer Vital GmbH: Competitive Position 2010
    • Beiersdorf AG in Consumer Health (germany)
    • Strategic Direction
    • Key Facts
  • Summary 5 Beiersdorf AG: Key Facts
  • Summary 6 Beiersdorf AG: Operational Indicators
    • Company Background
    • Production
  • Summary 7 Beiersdorf AG: Production Statistics 2010
    • Competitive Positioning
  • Summary 8 Beiersdorf AG: Competitive Position 2010
    • Boehringer Ingelheim Pharma GmbH & Co Kg in Consumer Health (germany)
    • Strategic Direction
    • Key Facts
  • Summary 9 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts
  • Summary 10 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators
    • Company Background
    • Production
  • Summary 11 Boehringer Ingelheim Pharma GmbH & Co KG: Production Statistics 2010
    • Competitive Positioning
  • Summary 12 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2010
    • Ratiopharm GmbH & Co in Consumer Health (germany)
    • Strategic Direction
    • Key Facts
  • Summary 13 Ratiopharm GmbH & Co: Key Facts
  • Summary 14 Ratiopharm GmbH & Co: Operational Indicators
    • Company Background
    • Production
  • Summary 15 Ratiopharm GmbH & Co: Production Statistics 2010
    • Competitive Positioning
  • Summary 16 Ratiopharm GmbH & Co: Competitive Position 2010
    • Stada Arzneimittel AG in Consumer Health (germany)
    • Strategic Direction
    • Key Facts
  • Summary 17 STADA Arzneimittel AG: Key Facts
  • Summary 18 STADA Arzneimittel AG: Operational Indicators
    • Company Background
    • Production
  • Summary 19 STADA Arzneimittel AG: Production Statistics 2010
    • Competitive Positioning
  • Summary 20 STADA Arzneimittel AG: Competitive Position 2010
    • Executive Summary
    • Consumer Health in Germany Stagnated in 2010
    • the Health and Wellness Trend Is Having A Negative Impact on Consumer Health Sales
    • Bayer Vital GmbH Remains the Leading Manufacturer of Consumer Health Products in Germany
    • Chemists/pharmacies Continues To Be the Most Common Outlet for Consumer Health Products
    • Consumer Health Sales Value Is Predicted To Decline During the Forecast Period
    • Key Trends and Developments
    • Increased Interest in Health and Wellness Leads To A Slowdown in OTC Sales
    • Consumer Health Sales Through Internet Retailing Are Becoming Increasingly Popular
    • Consumer Insecurities Affect the Consumer Health Category
    • Innovation Is Key for the Survival of Premium Brands
    • Self-medication in Germany
    • Market Indicators
    • Market Data
    • OTC Registration and Classification
    • Vitamins and Dietary Supplements Registration and Classification
    • Self-medication/self-care and Preventative Medicine
  • Summary 21 OTC Healthcare Switches 2008-2010
    • Definitions
    • Sources
  • Summary 22 Research Sources
  • List of Tables
    • Table 1 Sales of Analgesics by Category: Value 2005-2010
    • Table 2 Sales of Analgesics by Category: % Value Growth 2005-2010
    • Table 3 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
    • Table 4 Analgesics Company Shares by Value 2006-2010
    • Table 5 Analgesics Brand Shares by Value 2007-2010
    • Table 6 Forecast Sales of Analgesics by Category: Value 2010-2015
    • Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015
    • Table 8 Consumer Expenditure on Health Goods and Medical Services 2005-2010
    • Table 9 Life Expectancy at Birth 2005-2010
    • Table 10 Sales of Consumer Health by Category: Value 2005-2010
    • Table 11 Sales of Consumer Health by Category: % Value Growth 2005-2010
    • Table 12 Consumer Health Company Shares by Value 2006-2010
    • Table 13 Consumer Health Brand Shares by Value 2007-2010
    • Table 14 Penetration of Private Label by Category 2005-2010
    • Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
    • Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
    • Table 17 Forecast Sales of Consumer Health by Category: Value 2010-2015
    • Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015